OKLO Oklo Inc. Insider Trading

CEO Jacob Dewitte sells 200,000 shares (200.0K) for $13.7M; 10b5-1 plan; stock up 11.9% in 90 days post-sale.

Jacob Dewitte, Co-Founder and CEO, executed 8 separate sales totaling 200,000 shares for $13,657,879.60 on 2026-06-01, reducing his stake by 24.7%. This transaction was executed under a pre-arranged 10b5-1 trading plan adopted on 2025-03-31, meaning it was scheduled rather than discretionary. Post-transaction, the stock has appreciated 11.9% over the past 90 days and currently trades at $73.47 versus the blended average sale price of $68.29. Notably, his five prior OKLO sales in May 2026 all generated negative 30-day and 90-day returns (ranging from -3.1% to -5.7%), whereas his broader cross-ticker track record shows average 90-day returns of +16.9% after prior sells; this June sale has benefited from subsequent price appreciation, a different outcome than his recent OKLO pattern. The company reported net income of -$33,065,000.00 for its most recent full fiscal year, placing the transaction within an unprofitable operational context.

Co-founder Caroline Cochran sells 200,000 OKLO shares for $13.7M via scheduled 10b5-1 plan on 2026-06-01

Caroline Cochran, who was COO at the time of this transaction, executed 8 separate sales totaling 200,000 shares for $13,657,879.60 at prices ranging from $64.99 to $70.45, reducing her holdings by 25.8% from 776,483 to 576,483 shares. This transaction is part of a pre-arranged 10b5-1 trading plan adopted on 2025-03-31, making it a scheduled execution rather than a discretionary trade. Notably, the company reported a net loss of $33,065,000 over its most recent full fiscal year, indicating ongoing unprofitability despite the multi-billion-dollar market cap. At the same ticker, Cochran's prior 5 sells (all on 2026-05-01) each subsequently declined 3.2% to 5.7% over both 30-day and 90-day periods, whereas her cross-ticker track record of 20 prior sells shows average positive returns of +14.7% at 30 days and +16.9% at 90 days—establishing a material divergence between her general timing accuracy and her outcomes at OKLO specifically.

Chief Legal & Strategy Officer sells 10,548 shares of OKLO at $58.04; stock currently at $65.09, down 66.4% from 52-week high of $193.84

William Carroll Murphy Goodwin, Chief Legal & Strategy Officer, sold 10,548 shares at $58.04 on 2026-05-20, reducing his stake by 22.6% to 36,175 shares post-transaction. The current price of $65.09 is 66.4% below the 52-week high of $193.84, indicating significant markdown from recent peaks. At OKLO specifically, Goodwin's prior four trades show mixed timing patterns: two of the four prior sells at 90 days were well-timed (stock fell after), but the most recent March 2026 sale gained 25.7% in 30 days before the current decline. The company reported net income of $-33,065,000.00 over its most recent full fiscal year, meaning operations are unprofitable despite the $11.3B market capitalization. This sale occurs in a context of substantial stock depreciation and persistent losses, though without an earnings or announcement trigger in this filing, the discrete motivation is not disclosed.

CFO Bealmear exercises options and sells shares, netting 5,880 additional shares while stock trades 58% below 52-week high.

Richard Craig Bealmear, Oklo's CFO, executed a mixed transaction sequence: exercising two option grants totaling over 22,000 shares at a below-market strike price, then immediately selling 16,216 shares at a dramatically higher price. The net effect is a modest 5,880-share increase in his holdings, which now total approximately 398,000 shares. This pattern—exercise followed by partial offset sale—is typical of option liquidity management and does not necessarily reflect conviction about the stock's direction. Of greater note is Bealmear's track record at this ticker: his five prior sales over the past several months were well-timed on three occasions (the stock fell afterward, validating his exits) and poorly-timed on two occasions (the stock rose, meaning he sold too early). This mixed but slightly favorable record suggests he has some credibility reading the company's short-term momentum. However, the company is currently unprofitable with recent quarterly losses exceeding $60 million, and the stock trades well below its 52-week high after a significant recent pullback—a context where even a CFO's timing edge carries meaningful uncertainty. The exercise itself is routine compensation execution, but the timing of the sale during a period of negative price momentum and weak fundamentals warrants tracking whether Bealmear continues this disposition pattern or returns to accumulation.

Co-founder and COO Caroline Cochran sells ~200k shares worth $14M as Oklo trades well below recent highs amid losses

Caroline Cochran, Oklo's Co-founder and COO, executed a substantial single-day sell-off of roughly 200,000 shares totaling over $14 million. What makes this significant is the context: the stock is trading nearly 60% below its recent highs, yet Cochran—someone with direct operational insight into the company—is liquidating a meaningful portion of her holdings rather than adding to positions during a pullback. This is the opposite of the "buying the dip" signal investors typically watch for from insiders. Oklo remains unprofitable with mounting quarterly losses, so Cochran's decision to exit at this valuation level suggests either a need for capital diversification or reduced confidence in near-term recovery prospects. The sheer size and diversity of tranches (six separate transactions across slightly varying prices) signals this was a deliberate, methodical liquidation rather than an accidental or forced sale.

Oklo Co-Founder and CEO sells 200K shares in six separate transactions, largest insider sale in months from company leadership.

Dewitte Jacob, Oklo's Co-Founder and CEO, executed a significant liquidation of 200,000 shares over a single trading day, representing approximately 27% of his holdings. This is the 113th open-market sale he has made in the past 36 months—a pattern of consistent selling with no open-market purchases during this period. The timing is notable: while Oklo trades well below its 52-week high and the company remains unprofitable, Jacob is selling into strength from a recent surge in share price. His prior five sales at Oklo all resulted in the stock rising afterward, indicating uniformly poor timing on his previous exits—he has never captured a well-timed sale at this company. The size and frequency of Jacob's selling, combined with his track record of exiting before subsequent gains, suggests ongoing portfolio reduction from the company's leadership rather than conviction about value at current levels.